These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 15964400

  • 21. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y, Ohashi K, Miyazawa M, Nakano M, Kobayashi T, Yamashita T, Akiyama H, Sakamaki H.
    Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
    [Abstract] [Full Text] [Related]

  • 22. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome.
    Li CK, Shing MM, Chik KW, Lee V, Leung TF, Cheung AY, Yuen MP.
    Bone Marrow Transplant; 2002 Jan; 29(2):101-5. PubMed ID: 11850702
    [Abstract] [Full Text] [Related]

  • 23. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A, Kobayashi R, Yoshida M, Kobayashi K, Matsuo K, Kitajima I, Maruyama I.
    Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
    [Abstract] [Full Text] [Related]

  • 24. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
    Peres E, Kintzel P, Dansey R, Baynes R, Abidi M, Klein J, Ibrahim RB, Abella E.
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
    [Abstract] [Full Text] [Related]

  • 25. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Lee SH, Yoo KH, Sung KW, Koo HH, Kwon YJ, Kwon MM, Park HJ, Park BK, Kim YY, Park JA, Im HJ, Seo JJ, Kang HJ, Shin HY, Ahn HS.
    Bone Marrow Transplant; 2010 Aug; 45(8):1287-93. PubMed ID: 20010866
    [Abstract] [Full Text] [Related]

  • 26. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
    Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N.
    Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
    [Abstract] [Full Text] [Related]

  • 27. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome.
    Brugieres L, Hartmann O, Benhamou E, Zafrani ES, Caillaud JM, Patte C, Kalifa C, Flamant F, Lemerle J.
    Bone Marrow Transplant; 1988 Jan; 3(1):53-8. PubMed ID: 3048471
    [Abstract] [Full Text] [Related]

  • 28. Hyperbilirubinemia in the early phase after allogeneic HSCT: prognostic significance of the alkaline phosphatase/total bilirubin ratio.
    Ashizawa M, Oshima K, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Machishima T, Kimura S, Kikuchi M, Nakasone H, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y.
    Bone Marrow Transplant; 2013 Jan; 48(1):94-8. PubMed ID: 22750996
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The impact of hepatitis B virus infected patients or donors on the outcome of hematopoietic stem cell transplantation].
    Feng S, Han M, Zhang L, Li C, Qiu L, Li H, Wang Z, Jiang R, Yan W, Han Z.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):414-6. PubMed ID: 11877014
    [Abstract] [Full Text] [Related]

  • 31. [Low dose heparin for the prevention of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation].
    Chen J, Zhu KE, Zhang T, Zhong J, Chen ST, Zeng HL.
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):140-2. PubMed ID: 17445443
    [Abstract] [Full Text] [Related]

  • 32. A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Park SH, Lee MH, Lee H, Kim HS, Kim K, Kim WS, Jung CW, Im YH, Yoon SS, Kang WK, Park K, Park CH, Kim SW.
    Bone Marrow Transplant; 2002 Jan; 29(2):137-43. PubMed ID: 11850708
    [Abstract] [Full Text] [Related]

  • 33. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention.
    Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, Straham B, Gross-Wieltsch U, Sykora KW, Ridolfi-Lüthy A, Basu O, Gruhn B, Güngör T, Mihatsch W, Schulz AS.
    Bone Marrow Transplant; 2004 Jan; 33(2):189-95. PubMed ID: 14661036
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
    Ringdén O, Remberger M, Lehmann S, Hentschke P, Mattsson J, Klaesson S, Aschan J.
    Bone Marrow Transplant; 2000 May; 25(9):993-6. PubMed ID: 10800069
    [Abstract] [Full Text] [Related]

  • 36. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
    Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C.
    Bone Marrow Transplant; 1991 Jun; 7(6):467-74. PubMed ID: 1908340
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
    Kaleelrahman M, Eaton JD, Leeming D, Bowyer K, Taberner D, Chang J, Scarffe JH, Chopra R.
    Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
    [Abstract] [Full Text] [Related]

  • 39. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 40. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L, McArthur J, Quasney MW, Pei D, Srivastava K, Dahmer MK, Barfield R.
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.